Market
What will be the primary outcome of Gates-Trump meeting on health by end of 2025?
2
Resolution / Starting Odds
New vaccine initiative • 25%
Increased funding • 25%
Policy change • 25%
No significant outcome • 25%
Reports from health organizations or media coverage
Story
Bill Gates 'Frankly Impressed' After Three-Hour Meeting with Trump on HIV and Vaccines
Jan 17, 2025, 08:26 PM
Bill Gates recently met with President-elect Donald Trump at Mar-a-Lago for a three-hour dinner to discuss global health issues, including HIV and polio vaccines. Gates, who is actively working on developing an AIDS vaccine through his foundation, sought Trump's assistance in fast-tracking vaccine development. Susie Wiles, a member of Trump's team, and Larry Cohen also attended the meeting. Gates acknowledged Trump's previous efforts in accelerating vaccine innovation during the COVID-19 pandemic and described Trump as 'energized and looking forward to' addressing global health challenges. Gates expressed that he was 'frankly impressed' with Trump's interest and enthusiasm.
View original story
Similar markets
Further meetings planned • 25%
Meeting inconclusive • 25%
No policy changes • 25%
Policy changes announced • 25%
Philanthropic collaboration • 25%
Business partnership • 25%
Personal visit • 25%
Political discussion • 25%
No new partnerships • 25%
Bilateral partnerships • 25%
Regional alliances • 25%
Other • 25%
Vaccination programs reduced • 25%
New safety studies announced • 25%
Vaccination programs ended • 25%
Vaccination programs unchanged • 25%
Other • 25%
No significant changes • 25%
Increased CDC funding • 25%
New health partnerships • 25%
Indifference • 25%
Majority opposition • 25%
Mixed reactions • 25%
Majority support • 25%
No state-level changes • 25%
Majority of states implement changes • 25%
Minority of states implement changes • 25%
Federal government mandates changes • 25%
Introduction of new vaccine safety measures • 25%
Reduction in number of vaccines • 25%
Complete overhaul of vaccination program • 25%
No changes to current vaccination program • 25%
US participates in new initiative • 25%
Other outcome • 25%
No new initiatives announced • 25%
US declines participation • 25%
Passed but not implemented • 25%
Withdrawn • 25%
Not passed • 25%
Passed and implemented • 25%